SRGA
Price:
$0.1829
Market Cap:
$1.68M
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of i...[Read more]
Industry
Medical - Devices
IPO Date
2000-08-11
Stock Exchange
NASDAQ
Ticker
SRGA
According to Surgalign Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -10506347.00. This represents a change of -205.99% compared to the average of 9.91M of the last 4 quarters.
The mean historical Enterprise Value of Surgalign Holdings, Inc. over the last ten years is 4.24B. The current -10506347.00 Enterprise Value has changed -124.76% with respect to the historical average. Over the past ten years (40 quarters), SRGA's Enterprise Value was at its highest in in the March 2019 quarter at 12.08B. The Enterprise Value was at its lowest in in the June 2022 quarter at 3.39M.
Average
4.24B
Median
5.89B
Minimum
6.94M
Maximum
8.91B
Discovering the peaks and valleys of Surgalign Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 47.90%
Maximum Annual Enterprise Value = 8.91B
Minimum Annual Increase = -97.35%
Minimum Annual Enterprise Value = 6.94M
Year | Enterprise Value | Change |
---|---|---|
2022 | 6.94M | -85.08% |
2021 | 46.52M | -61.11% |
2020 | 119.63M | -36.22% |
2019 | 187.57M | -97.35% |
2018 | 7.09B | -3.75% |
2017 | 7.37B | 28.14% |
2016 | 5.75B | -17.04% |
2015 | 6.93B | -22.25% |
2014 | 8.91B | 47.90% |
2013 | 6.02B | -15.22% |
The current Enterprise Value of Surgalign Holdings, Inc. (SRGA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
57.70M
5-year avg
1.49B
10-year avg
4.24B
Surgalign Holdings, Inc.’s Enterprise Value is less than NuVasive, Inc. (2.91B), less than Paragon 28, Inc. (673.67M), less than Orthofix Medical Inc. (747.43M), less than SI-BONE, Inc. (646.09M), less than Avanos Medical, Inc. (1.22B), less than Aziyo Biologics, Inc. (40.84M), less than Establishment Labs Holdings Inc. (1.31B), less than CVRx, Inc. (143.62M), less than AxoGen, Inc. (614.50M), greater than Talis Biomedical Corporation (-38241629.00), less than Heart Test Laboratories, Inc. (-2254770.00), less than Tivic Health Systems, Inc. (-1665400.00), less than Bone Biologics Corporation (-188370.00), less than Bioventus Inc. (984.03M), less than Surmodics, Inc. (563.14M), less than Biomerica, Inc. (2.45M), less than Movano Inc. (14.05M), less than Ainos, Inc. (10.30M), less than INVO Bioscience, Inc. (7.38M), less than Hyperfine, Inc. (11.71M), less than Inogen, Inc. (187.98M), less than Accelerate Diagnostics, Inc. (74.79M), less than Apyx Medical Corporation (51.06M),
Company | Enterprise Value | Market cap |
---|---|---|
2.91B | $2.08B | |
673.67M | $609.86M | |
747.43M | $619.96M | |
646.09M | $631.67M | |
1.22B | $1.09B | |
40.84M | $24.21M | |
1.31B | $1.16B | |
143.62M | $183.44M | |
614.50M | $570.66M | |
-38241629.00 | $2.83M | |
-2254770.00 | $2.52M | |
-1665400.00 | $2.03M | |
-188370.00 | $2.14M | |
984.03M | $621.23M | |
563.14M | $553.99M | |
2.45M | $5.84M | |
14.05M | $30.77M | |
10.30M | $4.42M | |
7.38M | $2.95M | |
11.71M | $65.36M | |
187.98M | $268.02M | |
74.79M | $40.97M | |
51.06M | $45.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surgalign Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surgalign Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Surgalign Holdings, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Surgalign Holdings, Inc. (SRGA)?
What is the 3-year average Enterprise Value for Surgalign Holdings, Inc. (SRGA)?
What is the 5-year average Enterprise Value for Surgalign Holdings, Inc. (SRGA)?
How does the current Enterprise Value for Surgalign Holdings, Inc. (SRGA) compare to its historical average?